NL-OMON33145已完成不适用
Evaluating small bowel wall in Crohn's disease: a comparison of MR enterography and contrast-enhanced ultrasound - Contrast-enhanced ultrasound in the diagnosis of Crohn's disease
Rijnstate Ziekenhuis0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- age between 18-65 years old;
- •- confirmed Crohn*s disease by ileocolonoscopy with biopsies;
- •- informed consent;
排除标准
- •- cardiac failure (acute or chronic NYHA class II -IV) or other heart disease (unstable angina pectoris, recent acute coronary syndrome, severe rhythm disorders), right-to-left cardiac shunts, uncontrolled systemic hypertension, severe pulmonary hypetension and adult respiratory distress syndrome, which contraindicate the use of intravenous contrast during CE-US;
- •- chronic end stage kidney disease (risk for nephrogenic systemic sclerosis by use of MRI contrast agent: Gadolinium);
- •- patients having absolute contraindications for the MRI (intracorporal metal clips, neurostimulator, insuline pomp or pacemaker);
- •- patients with an acute abdomen and indication for surgery;
- •- pregnancy and lactation;
研究者
相似试验
进行中（未招募）
不适用
Response Assessment in SB CDSmall Bowel Crohn's DiseaseNCT03646708Washington University School of Medicine112
进行中（未招募）
1 期
Bloodflow measurements in stenotic inflammatory bowel disease.EUCTR2011-005846-36-DKGastroenterology MIDT25
已完成
4 期
Adalimumab-psoriasis and Small Bowel LesionsCrohn's DiseasePlaque PsoriasisNCT01556672Innovaderm Research Inc.100
已完成
2 期
STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's DiseaseFibrostenotic Crohn's DiseaseNCT05843578Agomab Spain S.L.U.103
招募中
不适用
Validation of biomarkers for Crohn*s disease using peripheral blood cells of patientsulcerative colitiscrohn's diseaseNL-OMON48615Vrije Universiteit Medisch Centrum200